688098.SH
申联生物
SSE · Healthcare · Biotechnology · CN
CNY 8.00
−3.03%Margins
Gross margin
57.7%
EBITDA margin
17.3%
EBIT margin
-9.8%
Net margin
-7.1%
FCF margin
-7.5%
-1.4%
Return on equity
-1.3%
Return on assets
-1.9%
Return on invested capital
0.18x
Asset turnover
CNY 21.6M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026